|
(Health-NewsWire.Net, May 16, 2015 ) Global Markets Direct’s, ‘Pulmonary Hypertension Pipeline Review, H1 2015′, provides an overview of the Pulmonary Hypertension’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Pulmonary Hypertension, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pulmonary Hypertension and special features on late-stage and discontinued projects.
Complete report on H1 2015 pipeline review of “Pulmonary Hypertensionc” addition with 71 market data tables and 17 figures, spread across 226 pages is available http://www.rnrmarketresearch.com/pulmonary-hypertension-pipeline-review-h1-2015-market-report.html . (This is a premium report price at US$2000 for a single user PDF license)
The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Scope:
• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in the therapeutics development for Pulmonary Hypertension and enlists all their major and minor projects
• The report summarizes all the dormant and discontinued pipeline projects
• A review of the Pulmonary Hypertension products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
• Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• A detailed assessment of monotherapy and combination therapy pipeline projects
• Coverage of the Pulmonary Hypertension pipeline on the basis of target, MoA, route of administration and molecule type
Inquire for discount on this report at http://www.rnrmarketresearch.com/contacts/discount?rname=310130 .
Reasons to Buy:
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop strategic initiatives by understanding the focus areas of leading companies
• Identify and understand important and diverse types of therapeutics under development for Pulmonary Hypertension
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Devise corrective measures for pipeline projects by understanding Pulmonary Hypertension pipeline depth and focus of Indication therapeutics
More reports on Hypertension Drugs :
Global Nisoldipine Industry Report 2015
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Nisoldipine market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost price and production value gross margins.
Complete report is available at http://www.rnrmarketresearch.com/global-nisoldipine-industry-report-2015-market-report.html .
RnR Market Research
Ritesh Tiwari
+ 1-888-391-5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
|
